A significant number of breast cancer survivors who experienced heart problems as a side effect of their treatment may not require lifelong precautionary heart medication, according to findings from a new clinical trial. The study, described as "hugely encouraging," suggests that the majority of these patients can safely stop taking heart drugs.
Lucy Shepherd, a breast cancer survivor, shared her experience, stating that participating in the trial and subsequently stopping her heart medication has improved her life. She reported no longer living "with the same fear" of potential cardiac decline. Shepherd was diagnosed with triple-positive breast cancer shortly after her 33rd birthday, and a routine scan revealed her heart function had decreased during her treatment.
The trial, funded by the British Heart Foundation, involved 90 women in their 40s and 50s across four UK hospitals. These participants had shown recovery in their heart function after receiving a specific type of breast cancer treatment. Typically, such patients would be advised to remain on heart medication indefinitely due to concerns about potential future heart function deterioration.
However, the research found that 98% of the patients who discontinued their medication showed no change in heart function one year later. Only one woman in the group developed an issue with her heart's pumping ability. Participants who stopped taking the drugs also reported a better quality of life in questionnaires.
This development offers a hopeful outlook for breast cancer survivors, potentially reducing the long-term burden of medication and its associated side effects, while improving overall well-being.